Head Injury in an Age-Related Alzheimer Mouse Model Leads to an Altered Neuroinflammatory Response and Persistent Cognitive Impairment

Epidemiological studies have associated increased risk of Alzheimer's disease (AD)-related clinical symptoms with a medical history of head injury. Currently, little is known about pathophysiology mechanisms linked to this association. Persistent neuroinflammation is one outcome observed in patients after a single head injury. Neuroinflammation is also present early in relevant brain regions during AD pathology progression. In addition, previous mechanistic studies in animal models link neuroinflammation as a contributor to neuropathology and cognitive impairment in traumatic brain injury (TBI) or AD-related models. Therefore, we explored the potential interplay of neuroinflammatory responses in TBI and AD by analysis of the temporal neuroinflammatory changes after TBI in an AD model, the APP/PS1 knock-in (KI) mouse. Discrete temporal aspects of astrocyte, cytokine, and chemokine responses in the injured KI mice were delayed compared with the injured wild-type mice, with a peak neuroinflammatory response in the injured KI mice occurring at 7 d after injury. The neuroinflammatory responses were more persistent in the injured KI mice, leading to a chronic neuroinflammation. At late time points after injury, KI mice exhibited a significant impairment in radial arm water maze performance compared with sham KI mice or injured wild-type mice. Intervention with a small-molecule experimental therapeutic (MW151) that selectively attenuates proinflammatory cytokine production yielded improved cognitive behavior outcomes, consistent with a link between neuroinflammatory responses and altered risk for AD-associated pathology changes with head injury.

[1]  L. J. Eldik,et al.  Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug , 2008, Journal of Neuroimmunology.

[2]  D. Loane,et al.  Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention , 2012, Brain, Behavior, and Immunity.

[3]  E. McNeil,et al.  Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease , 2007, Experimental Neurology.

[4]  M. Simard,et al.  The neurobiology of glia in the context of water and ion homeostasis , 2004, Neuroscience.

[5]  Maia Parsadanian,et al.  Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model. , 2014, Journal of neurotrauma.

[6]  L. V. Van Eldik,et al.  Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration , 2006 .

[7]  A. Viola,et al.  Chemokines and their receptors: drug targets in immunity and inflammation. , 2008, Annual review of pharmacology and toxicology.

[8]  M. Wald,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .

[9]  B. Strooper,et al.  FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction , 2002, Neurobiology of Aging.

[10]  D. Perl,et al.  Dementia resulting from traumatic brain injury: what is the pathology? , 2012, Archives of neurology.

[11]  J. Godbout,et al.  Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease , 2015, Neuropharmacology.

[12]  J. Cooper,et al.  An Anti-Neuroinflammatory That Targets Dysregulated Glia Enhances the Efficacy of CNS-Directed Gene Therapy in Murine Infantile Neuronal Ceroid Lipofuscinosis , 2014, The Journal of Neuroscience.

[13]  R. Keep,et al.  Acute White Matter Injury After Experimental Subarachnoid Hemorrhage: Potential Role of Lipocalin 2 , 2014, Stroke.

[14]  L. V. Van Eldik,et al.  Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease , 2013, Alzheimer's Research & Therapy.

[15]  Jan Albrecht,et al.  Regulation of pH in the mammalian central nervous system under normal and pathological conditions: Facts and hypotheses , 2008, Neurochemistry International.

[16]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[17]  D. Graham,et al.  Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. , 1993, Neuroscience letters.

[18]  S. Frautschy,et al.  Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo , 2004, Neurobiology of Aging.

[19]  Y. Matsuoka,et al.  Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury , 2009, Nature Medicine.

[20]  L. V. Van Eldik,et al.  Glial Activation Links Early‐Life Seizures and Long‐Term Neurologic Dysfunction: Evidence Using a Small Molecule Inhibitor of Proinflammatory Cytokine Upregulation , 2007, Epilepsia.

[21]  L. J. Eldik,et al.  Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury , 2008, Journal of Neuroinflammation.

[22]  J. Trojanowski,et al.  Brain Trauma in Aged Transgenic Mice Induces Regression of Established Aβ Deposits , 2000, Experimental Neurology.

[23]  L. J. Eldik,et al.  Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a ‘two-hit’ seizure model , 2009, Brain Research.

[24]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[25]  M. Tansey,et al.  Journal of Neuroinflammation BioMed Central Review , 2008 .

[26]  B. Greenberg,et al.  Enhanced Amyloidogenic Processing of the β-Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a “Humanized” Aβ Sequence* , 1996, The Journal of Biological Chemistry.

[27]  M. Morganti-Kossmann,et al.  The Role of Markers of Inflammation in Traumatic Brain Injury , 2013, Front. Neurol..

[28]  A. Mantovani,et al.  The yin-yang of long pentraxin PTX3 in inflammation and immunity , 2014, Immunology Letters.

[29]  M. Vitek,et al.  A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.

[30]  Michael M. Halassa,et al.  Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. , 2010, Annual review of physiology.

[31]  S. DeKosky,et al.  Simvastatin therapy prevents brain trauma‐induced increases in β‐amyloid peptide levels , 2009, Annals of neurology.

[32]  Stephen L. Brown,et al.  Selective Inhibition of Microglia-Mediated Neuroinflammation Mitigates Radiation-Induced Cognitive Impairment , 2013, Radiation research.

[33]  P. Magistretti,et al.  Astrocyte–neuron metabolic relationships: for better and for worse , 2011, Trends in Neurosciences.

[34]  B. Gusterson,et al.  Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain , 2001, Glia.

[35]  L. J. Eldik,et al.  Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation , 2007, Journal of Molecular Neuroscience.

[36]  R. Myers,et al.  A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. , 2013, Cell reports.

[37]  M. Murphy,et al.  Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease , 2012, The Journal of Neuroscience.

[38]  T. Kossmann,et al.  Modulation of immune response by head injury. , 2007, Injury.

[39]  N. Rothwell,et al.  The Acute-Phase Protein PTX3 is an Essential Mediator of Glial Scar Formation and Resolution of Brain Edema after Ischemic Injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  L. J. Eldik,et al.  Sanders-brown Center on Aging Faculty Publications Aging Attenuation of Traumatic Brain Injury-induced Cognitive Impairment in Mice by Targeting Increased Cytokine Levels with a Small Molecule Experimental Therapeutic Repository Citation "attenuation of Traumatic Brain Injury-induced Cognitive Impai , 2022 .

[41]  V. Perry,et al.  Microglial priming in neurodegenerative disease , 2014, Nature Reviews Neurology.

[42]  Ben A. Barres,et al.  Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.

[43]  D. Diamond,et al.  Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice , 2006, Nature Protocols.

[44]  Kimelberg Hk.  Astrocytic edema in CNS trauma. , 1992 .

[45]  Toshiro K. Ohsumi,et al.  The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.

[46]  R. Deacon,et al.  Assessing Burrowing, Nest Construction, and Hoarding in Mice , 2012, Journal of visualized experiments : JoVE.

[47]  T. Wyss-Coray,et al.  Microglial dysfunction in brain aging and Alzheimer's disease. , 2014, Biochemical pharmacology.

[48]  R. Deacon.  Assessing nest building in mice , 2006, Nature Protocols.

[49]  E. Capetillo-Zarate,et al.  Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.

[50]  Michael Chopp,et al.  Animal models of traumatic brain injury , 2013, Nature Reviews Neuroscience.

[51]  S. Gygi,et al.  Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia , 2013, Nature Neuroscience.

[52]  M. Sofroniew,et al.  Neurological diseases as primary gliopathies: a reassessment of neurocentrism , 2012, ASN neuro.

[53]  M. Sofroniew.  Multiple Roles for Astrocytes as Effectors of Cytokines and Inflammatory Mediators , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[54]  R. Ransohoff,et al.  The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.

[55]  W. Markesbery,et al.  Aβ solubility and deposition during AD progression and in APP×PS-1 knock-in mice , 2007, Neurobiology of Disease.

[56]  The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood , 2012, The Journal of Immunology.

[57]  S. Akira,et al.  Lipocalin 2 Plays an Immunomodulatory Role and Has Detrimental Effects after Spinal Cord Injury , 2011, The Journal of Neuroscience.

[58]  S. Goderie,et al.  Astrocytic Swelling Due to Hypotonic or High K+ Medium Causes Inhibition of Glutamate and Aspartate Uptake and Increases Their Release , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  B. Barres,et al.  Genomic Analysis of Reactive Astrogliosis , 2012, The Journal of Neuroscience.

[60]  Janna H. Neltner,et al.  Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology , 2012, The Journal of Neuroscience.

[61]  M. Sofroniew,et al.  Essential protective roles of reactive astrocytes in traumatic brain injury. , 2006, Brain : a journal of neurology.

[62]  L. V. Van Eldik,et al.  Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain , 2013, Journal of Neuroinflammation.

[63]  M. Vitek,et al.  Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic. , 2010, Journal of neurotrauma.

[64]  Myungwon Jin,et al.  Lipocalin-2 Deficiency Attenuates Neuroinflammation and Brain Injury after Transient Middle Cerebral Artery Occlusion in Mice , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  D. Flood,et al.  Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability , 2000, The Journal of Neuroscience.

[66]  C. Norris,et al.  Calcium dysregulation and neuroinflammation: Discrete and integrated mechanisms for age-related synaptic dysfunction , 2013, Ageing Research Reviews.

[67]  D. Loane,et al.  Role of microglia in neurotrauma , 2010, Neurotherapeutics.

[68]  M. Wainwright,et al.  Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures. , 2010, Journal of neurotrauma.

[69]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[70]  D. Sharp,et al.  Inflammation after trauma: Microglial activation and traumatic brain injury , 2011, Annals of neurology.

[71]  D. Holtzman,et al.  Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study , 2010, Neurobiology of Disease.

[72]  T. Wyss-Coray,et al.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.

[73]  Philip V Bayly,et al.  Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury. , 2007, Journal of neurotrauma.

[74]  A. Schousboe,et al.  Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission , 2004, Neurochemistry International.

[75]  D. Holtzman,et al.  Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury , 2006, Experimental Neurology.

[76]  L. V. Van Eldik,et al.  Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits. , 2007, Bioorganic & medicinal chemistry letters.

[77]  J. Trojanowski,et al.  Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis , 2002, The Journal of Neuroscience.

[78]  Melissa D. Laird,et al.  Opposing Roles for Reactive Astrocytes following Traumatic Brain Injury , 2008, Neurosignals.

[79]  L. V. Van Eldik,et al.  The p38α MAPK Regulates Microglial Responsiveness to Diffuse Traumatic Brain Injury , 2013, The Journal of Neuroscience.

[80]  D. Graham,et al.  β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury , 1993, Neuroscience Letters.

[81]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[82]  Richard J. Kryscio,et al.  Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort , 2013, Dementia and Geriatric Cognitive Disorders.

[83]  S. DeKosky,et al.  Caspase inhibition therapy abolishes brain trauma-induced increases in Aβ peptide: Implications for clinical outcome , 2006, Experimental Neurology.

[84]  D. Holtzman,et al.  Controlled Cortical Impact Traumatic Brain Injury in 3xTg-AD Mice Causes Acute Intra-Axonal Amyloid-β Accumulation and Independently Accelerates the Development of Tau Abnormalities , 2011, The Journal of Neuroscience.

[85]  F. Sherriff,et al.  Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein , 2004, Acta Neuropathologica.

[86]  L. V. Van Eldik,et al.  Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. , 2007, International review of neurobiology.

[87]  Douglas H. Smith,et al.  Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? , 2010, Nature Reviews Neuroscience.

[88]  Toru Shimizu,et al.  Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular Aβ Aggregation in Alzheimer's Disease Transgenic Mice , 2013, PloS one.

[89]  S. Akira,et al.  Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis , 2012, Glia.

[90]  John Q. Trojanowski,et al.  Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury , 2004, Experimental Neurology.